1. Home
  2. INGN vs ANTX Comparison

INGN vs ANTX Comparison

Compare INGN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.31

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.93

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGN
ANTX
Founded
2001
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
172.9M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
INGN
ANTX
Price
$6.31
$4.93
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$11.25
$2.00
AVG Volume (30 Days)
195.1K
204.0K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
32.56
EPS
N/A
N/A
Revenue
$348,668,000.00
N/A
Revenue This Year
$8.03
N/A
Revenue Next Year
$7.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$1.00
52 Week High
$9.13
$6.91

Technical Indicators

Market Signals
Indicator
INGN
ANTX
Relative Strength Index (RSI) 48.07 56.12
Support Level $6.00 $3.91
Resistance Level $6.73 $5.15
Average True Range (ATR) 0.24 0.35
MACD -0.03 0.02
Stochastic Oscillator 41.79 71.30

Price Performance

Historical Comparison
INGN
ANTX

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: